| note related to this contribution
| - This work was initiated while these authors were members of the Drug Design and Synthesis Section, Laboratory of Medicinal Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, NIH.
- Drug Design and Synthesis Section, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, Department of Health and Human Services.
- Current address: Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno Kawauchi-cho, Tokushima 771-0192, Japan.
|
